Patents by Inventor Daichi Baba

Daichi Baba has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HEAD BIOLOGICAL SIGNAL DETECTION DEVICE AND BIOLOGICAL STATE ESTIMATION DEVICE
    Publication number: 20250311997
    Abstract: With a simple structure, to make it possible to detect a head biological signal that reflects the state of cerebral blood flow, and to make it possible to assess a sleep stage based on a variation in the cerebral blood flow. A head biological signal detection sensor is supported on the head using a sensor support member such that a connecting yarn sags to make an interval between a pair of facing ground knitted fabrics in a three-dimensional knitted fabric narrower than that under no load. With this configuration, microvibration occurring in yarns and fibers forming the three-dimensional knitted fabric of the head biological signal detection sensor or in other places due to head movement resulting from body motion or the like generates stochastic resonance, which makes it possible to detect a head biological signal.
    Type: Application
    Filed: October 28, 2022
    Publication date: October 9, 2025
    Applicant: DELTA TOOLING CO., LTD.
    Inventors: Etsunori FUJITA, Yumi OGURA, Ryuichi UCHIKAWA, Daichi BABA
  • Anti-Orai1 antibody
    Patent number: 10851162
    Abstract: It is intended to provide a therapeutic and/or prophylactic agent for transplant rejections, immunological diseases, allergic diseases, inflammatory diseases, thrombosis, cancers, etc., targeting human Orai1. The present invention provides, for example, a pharmaceutical composition comprising an antibody that specifically recognizes human Orai1 and has the activity of inhibiting human T cell activation.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: December 1, 2020
    Assignee: Daiichi Sankyo Company, Limited
    Inventors: Tomoaki Komai, Takako Kimura, Daichi Baba, Yoshikuni Onodera, Kento Tanaka, Takashi Kagari, Anri Aki, Nobumi Nagaoka
  • Anti-Orai1 Antibody
    Publication number: 20190322740
    Abstract: It is intended to provide a therapeutic and/or prophylactic agent for transplant rejections, immunological diseases, allergic diseases, inflammatory diseases, thrombosis, cancers, etc., targeting human Orai1. The present invention provides, for example, a pharmaceutical composition comprising an antibody that specifically recognizes human Orai1 and has the activity of inhibiting human T cell activation.
    Type: Application
    Filed: July 2, 2019
    Publication date: October 24, 2019
    Applicant: Daiichi Sankyo Company, Limited
    Inventors: Tomoaki Komai, Takako Kimura, Daichi Baba, Yoshikuni Onodera, Kento Tanaka, Takashi Kagari, Anri Aki, Nobumi Nagaoka
  • Anti-Orai1 antibody
    Patent number: 10351624
    Abstract: It is intended to provide a therapeutic and/or prophylactic agent for transplant rejections, immunological diseases, allergic diseases, inflammatory diseases, thrombosis, cancers, etc., targeting human Orai1. The present invention provides, for example, a pharmaceutical composition comprising an antibody that specifically recognizes human Orai1 and has the activity of inhibiting human T cell activation.
    Type: Grant
    Filed: August 6, 2015
    Date of Patent: July 16, 2019
    Assignee: Daiichi Sankyo Company, Limited
    Inventors: Tomoaki Komai, Takako Kimura, Daichi Baba, Yoshikuni Onodera, Kento Tanaka, Takashi Kagari, Anri Aki, Nobumi Nagaoka
  • Anti-Orai1 Antibody
    Publication number: 20170226203
    Abstract: It is intended to provide a therapeutic and/or prophylactic agent for transplant rejections, immunological diseases, allergic diseases, inflammatory diseases, thrombosis, cancers, etc., targeting human Orai1. The present invention provides, for example, a pharmaceutical composition comprising an antibody that specifically recognizes human Orai1 and has the activity of inhibiting human T cell activation.
    Type: Application
    Filed: August 6, 2015
    Publication date: August 10, 2017
    Applicant: Daiichi Sankyo Company, Limited
    Inventors: Tomoaki Komai, Takako Kimura, Daichi Baba, Yoshikuni Onodera, Kento Tanaka, Takashi Kagari, Anri Aki, Nobumi Nagaoka